Abiomed, Inc.ABMDNASDAQ
Loading
Cash Flow PerformanceNormalizing
Percentile Rank71
3Y CAGR-0.2%
5Y CAGR+6.8%
Year-over-Year Change
Free cash flow yield
3Y CAGR
-0.2%/yr
vs +6.2%/yr prior
5Y CAGR
+6.8%/yr
Recent deceleration
Acceleration
-6.5pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive growthNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2022 | 1.66% | +7.9% |
| 2021 | 1.54% | -62.8% |
| 2020 | 4.13% | +147.5% |
| 2019 | 1.67% | +56.9% |
| 2018 | 1.06% | -11.0% |
| 2017 | 1.20% | -21.8% |
| 2016 | 1.53% | +16.7% |
| 2015 | 1.31% | -35.2% |
| 2014 | 2.02% | -38.6% |
| 2013 | 3.29% | - |